Toxicology results in for Chester Bennington

Posted by on December 5, 2017

UPDATE: Linkin park’s Mike Shinoda has taken to Twitter last night (5th) to confirm that the toxicology report TMZ released earlier was fabricated. TMZ has since updated their story stating that despite the initial toxicology report found traces of MDMA (ecstasy) in his system were positive, there were two subsequent tests that came back negative. 

Shinoda stated:

“Just clearing this up: TMZ erroneously printed CB had MDMA in his system when he passed. That was incorrect, they misread the report. They have since corrected their piece, see below. I hope other publications have the decency to do the same.”

TMZ’s updated report:

“According to the autopsy and toxicology results, obtained by TMZ, the Linkin Park singer’s blood also tested “presumptive positive” for MDMA (ecstasy) … based on one test. Two subsequent tests did not detect the drug, and the ultimate conclusion was Chester was not under the influence of drugs when he died. “

 

 

Original Story:

We are approaching the five month mark since Chester Bennington took his own life on July 20th. Today (5th), long after Linkin Park’s tribute show,  TMZ reported Bennington’s autopsy report. Unfortunately, the results are shocking and unexpected. The autopsy report revealed he had alcohol and ecstasy in his system.

TMZ stated:

“According to the autopsy and toxicology results, obtained by TMZ, the Linkin Park singer had a small amount of alcohol and MDMA (ecstasy).

Authorities found a prescription bottle of Zolpidem — generic Ambien — on his dresser. There was also a pint glass of Corona, which was less than half full — and an empty bottle of Stella Artois.

Police found pieces of fingernail underneath his iPhone and on a table in the bedroom. Chester’s wife, Talinda, told cops he would do that when he was anxious. She said Chester had a history of depression and previous suicide attempts — including one in 2006 when he left the house with a gun after drinking heavily.”

 

Tags: ,

Categorised in: News